<DOC>
	<DOC>NCT00858702</DOC>
	<brief_summary>The purpose of the study is to test the efficacy and safety of the combination of Calcium Channel Blockers (CCBs)(of the dihydropyridine class) or Diuretics (of the thiazide class) and olmesartan medoxomil in essential hypertensive patients whose blood pressure is not adequately controlled with olmesartan medoxomil alone</brief_summary>
	<brief_title>Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Mean seated blood pressure greater than or equal to 140/90 mmHg under circumstances in pretreatment with olmesartan medoxomil Mean 24hour blood pressure evaluated by ambulatory blood pressure monitoring greater than or equal to 135/80 mmHg under circumstances in pretreatment with olmesartan medoxomil Patients with secondary hypertension Any serious disorder which may limit the ability to evaluate the efficacy or safety of the test drugs</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Essential hypertension</keyword>
	<keyword>Combination therapy</keyword>
</DOC>